Skip to main content
. 2019 Jul 25;63(8):e00240-19. doi: 10.1128/AAC.00240-19

TABLE 7.

Metabolites identified in pooled plasma following oral single-dose (25 mg) and repeat-dose (15 mg/day for 14 days) administration of GSK3036656a

Metabolite Proposed structure % oDRM, single dose (25 mg), day 1, 0–24 h % oDRM, repeat dose (15 mg), day 14, 0–24 h
P (GSK3036656) graphic file with name AAC.00240-19-f004a.jpg 100 100
M1 (GSK3635633), oxidation and deboronation graphic file with name AAC.00240-19-f004b.jpg ND ND
a

oDRM, observed drug-related material; ND, not detected.